Methodologic sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma

Human Pathology

Volumn 23, Issue 4, 1992, Pages 360-367

  Falkmer, Ursula G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA;

ANALYTICAL ERROR; ANEUPLOIDY; CANCER GROWTH; CONFERENCE PAPER; CYTOPATHOLOGY; DIAGNOSTIC VALUE; DIPLOIDY; DNA CONTENT; FLOW CYTOMETRY; HISTOGRAM; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TETRAPLOIDY; TRANSURETHRAL RESECTION; TUMOR CELL; TUMOR VOLUME;

DIAGNOSTIC ERRORS; DNA, NEOPLASM; FLOW CYTOMETRY; HUMAN; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0026773684     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(92)90082-E     Document Type: Article

References (52)

1. Cytophotometry
2. Methodological aspects on the value of flow and image cytometric nuclear DNA assessments of the neoplastic cells of prostatic adenocarcinoma
3. Methodological aspects on DNA cytometry. Image and flow cytometry on malignant tumors of the breast, the endometrium, the brain, and the salivary glands
4. Intratumoral variations in DNA distribution patterns in mammary adenocarcinomas
5. Efficacy of combined image and flow cytometric DNA assessments in human breast cancers. A methodological study based on routine histopathologic material of 2,024 excised tumor specimens
6. Methodological aspects on cytochemical DNA assessments of adenocarcinoma of the endometrium by means of image and flow cytometry using conventionally formalin-fixed and paraffin-embedded specimens
7. Variations in the Feulgen stainability of epithelial parenchymal cells extracted from paraffin-embedded salivary gland specimens
8. Methodological aspects of DNA assessments by means of image cytometry in tumors of the salivary glands. A comparison between the results obtained using sections and cytospin preparations from the same paraffin-embedded specimens
9. Methodological aspects on nuclear DNA assessment in gliomas with astrocytic and/or oligodendrocytic differentiation Correlation of image and flow cytometric studies on paraffin-embedded specimens
10. S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxy-uridine labeling
11. Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate
12. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an “endocrine marker”
13. Carcinoma of the prostate with Cushing's syndrome. A case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissue
14. Cytochemical markers and DNA content of neuroendocring cells in carcinoma of the prostate gland during tumour progression
15. Gleason histologic grading of prostatic carcinoma: Correlations between biopsy and prostatectomy specimens
16. The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade, volume and stage of the biopsied and multifocal tumor
17. Tumour ploidy and prognosis in carcinomas of the bladder and prostate
18. Flow cytometric analysis of localized adenocarcinoma of the prostate: The use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropubic prostatectomy
19. DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases
20. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis
21. DNA ploidy as prognostic factor in prostatic carcinoma
22. Stage C prostatic adenocarcinoma: Flow cytometric nuclear DNA ploidy analysis
23. Prognostic significance of the DNA ploidy in carcinoma of prostate
24. Prognosis in disseminated prostate cancer as related to tumor ploidy and differentiation
25. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate
26. Stage D1 prostatic adenocarcinoma: Significance of nuclear DNA ploidy patterns studied by flow cytometry
27. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: Influence of tumor deoxyribonucleic acid ploidy
28. Flow cytometric determination of ploidy in prostatic adenocarcinoma: A comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence
29. Flow cytometry of prostate cancer: Relationship of DNA content to survival
30. DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study
31. Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome
32. Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostatic specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma
33. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer
34. DNA pattern and cytological findings in fine-needle aspirates of untreated prostatic tumors. A flow-cytofluorimetric study
35. Cytophotometric DNA-analysis of aspirated cells from prostatic carcinoma
36. DNA grading of prostatic carcinoma Prognostic validity and reproducibility
37. Nuclear DNA analysis: The relevance of ploidy, DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma
38. Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma
39. Prognostic significance of the nuclear DNA content in localized prostatic adenocarcinoma
40. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry
41. Histologic grading and clinical staging of prostatic carcinoma
42. Grading of prostatic carcinoma
43. Uber die Klassifikation und Grading des Prostatacarcinoms
44. Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate
45. Natural history of localised prostatic cancer
46. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics
47. Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 409 consecutive cases
48. Quantitative and qualitative aspects of flow DNA measurements related to the cytologic grade in prostate carcinoma
49. Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms
50. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry